Alejandro Galindo - 18 May 2022 Form 4 Insider Report for MANNKIND CORP (MNKD)

Role
EVP Endocrine Business Unit
Signature
/s/ Alejandro Galindo
Issuer symbol
MNKD
Transactions as of
18 May 2022
Net transactions value
-$15,277
Form type
4
Filing time
20 May 2022, 20:00:47 UTC
Previous filing
12 May 2022
Next filing
24 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNKD Common Stock, $.01 Par Value Tax liability $15,277 -4,789 -0.62% $3.19 771,901 18 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units.